← Back to Search

Thyroid Hormone Replacement

Levothyroxine Sodium for Hypothyroidism

Phase 4
Waitlist Available
Led By Vijiya Surampudi, MD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Hypothyroid patients on levothyroxine tablet
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial will test a new liquid levothyroxine formula to see if it better manages thyroid function and improves symptoms of hypothyroidism.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are taking levothyroxine tablets for an underactive thyroid.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change of TSH
Secondary outcome measures
percentage of patients with therapeutic FT3
percentage of patients with therapeutic FT4

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Liquid Levothyroxine ManagementExperimental Treatment1 Intervention
Participants will be treated with dose equivalent regimen through enteral feeding tube
Group II: Standard Levothyroxine ManagementActive Control1 Intervention
Participants will continue with the same regimen
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Levothyroxine
FDA approved

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,521 Previous Clinical Trials
10,278,933 Total Patients Enrolled
Vijiya Surampudi, MDPrincipal InvestigatorUniversity of California, Los Angeles
1 Previous Clinical Trials
150 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What ailments does Levothyroxine Sodium commonly remediate?

"Levothyroxine Sodium has been clinically demonstrated to help manage malignant neoplasms, euthyroid goitre and even obesity."

Answered by AI

Is this research attempting to bring on additional participants?

"As per the information presented on clinicaltrials.gov, enrollment for this experiment is open and ongoing. This trial was posted to the site on May 5th 2021 with updates made as recently as May 4th 2021."

Answered by AI

What kind of risks does Levothyroxine Sodium pose for those taking it?

"The safety of Levothyroxine Sodium is highly rated with a score of 3 due to its Phase 4 status, which indicates that it has been approved by the relevant authorities."

Answered by AI

What is the upper limit for participant enrollment in this trial?

"Confirmed. According to clinicaltrials.gov, the trial which was posted on May 5th 2021 is currently accepting patients. Thirty-four participants must be enrolled from a single medical site and the last edit made to this study occurred on April 4th of this year."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
UCLA Center for Human Nutrition
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

help someone else along with my self also the money for the trial.
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Email
Phone Call
Most responsive sites:
  1. UCLA Center for Human Nutrition: < 24 hours
Average response time
  • < 1 Day
~1 spots leftby Mar 2025